— Johnson & Johnson’s announcement that it will exit the insulin pump businesses appears to benefit one San Diego company, Tandem Diabetes Care, and potentially hurt another, DexCom...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129